ALKS vs MDXG: fair value comparison
Alkermes plc and MiMedx Group, Inc. · Updated 2026-08-31
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, MDXG currently sits closer to the top of our discount ranking. ALKS carries the stronger quality grade.
| ALKS | MDXG | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $49.53 | $4.27 |
| 12-month range | $28.26–$51.72 | $3.58–$7.52 |
| Sector rank | #113 of 113 Healthcare | #106 of 113 Healthcare |
| Quality grade | A | D |
| Momentum grade | C | — |
| Leverage | Low | Low |
| Margin trend | Expanding | — |
| Revenue growth | Modest | — |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Downtrend |
| DCF cross-check | Undervalued | — |
| 52-week position | The top quarter | The bottom quarter |
Full single-stock breakdowns: ALKS fair value analysis · MDXG fair value analysis